Literature DB >> 10587336

Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response.

W Koenig1, D Rothenbacher, A Hoffmeister, M Miller, G Bode, G Adler, V Hombach, W März, M B Pepys, H Brenner.   

Abstract

BACKGROUND: There is controversy about the association between Helicobacter pylori infection and manifestations of coronary heart disease (CHD), the potential role of the more virulent H pylori strains, and whether or not a positive serostatus is related to increased levels of markers of systemic inflammation. METHODS AND
RESULTS: We assessed the prevalence of an infection with H pylori and in particular the anti-cytotoxin-associated protein A (CagA) antibody response of the more virulent strains expressing CagA in 312 patients with stable CHD and in 479 control subjects. Serological prevalence of H pylori infection (IgG titer) was significantly higher in patients than in control subjects after adjustment for age and sex (44.2% versus 31.3%, P<0.001). After adjustment for various covariates in multiple logistic regression, the odds ratio (OR) for CHD was 1.3 (95% CI, 0.9 to 1.9) given a positive IgG serostatus. The prevalence of CagA-positive strains was 27.9% in patients and 21.7% in control subjects (P=0.076 adjusted for age and sex). The OR for CHD in the fully adjusted model was 1.1 (95% CI, 0.7 to 1.7). None of the inflammatory markers (C-reactive protein, fibrinogen, plasma viscosity, or leukocytes) was significantly different according to serostatus.
CONCLUSIONS: In this large case-control study, the association of H pylori infection with stable CHD was strongly reduced and was no longer statistically significant after controlling for potential confounders. We also found no independent association between the more virulent strains and CHD. In addition, a positive serostatus was not associated with a systemic inflammatory response. Thus, these data do not support the hypothesis that infection with H pylori might be a major risk factor for stable CHD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587336     DOI: 10.1161/01.cir.100.23.2326

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Cross-reactivity of anti-H pylori antibodies with membrane antigens of human erythrocytes.

Authors:  Feng-Hua Guo; Xiao-Mei Yan; Chun-Xiang Fan; Fei Zhao; Yuan Hu; Di Xiao; Xun Zeng; Mao-Jun Zhang; Li-Hua He; Fan-Ling Meng; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

Review 2.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

3.  Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction.

Authors:  M Gunn; J C Stephens; J R Thompson; B J Rathbone; N J Samani
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

4.  Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities.

Authors:  N Figura; A Palazzuoli; S Faglia; C Lenzi; F Borrello; V Palazzuoli; R Nami; N Dal Canto; F De Regis; D Vaira; L Gennari; N Giordano; C Gennari
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

Review 5.  Fibrinogen and coronary risk.

Authors:  W Koenig
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

6.  Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A meta-analysis.

Authors:  Xin-Juan Yu; Xuan Yang; Lei Feng; Li-Li Wang; Quan-Jiang Dong
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

7.  The effect of different strains of Helicobacter pylori on platelet aggregation.

Authors:  Paul A Corcoran; John C Atherton; Steve W Kerrigan; Torkel Wadstrom; Frank E Murray; Richard M Peek; Desmond J Fitzgerald; Dermont M Cox; Michael F Byrne
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 8.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

9.  Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study.

Authors:  A F Stone; P Risley; H S Markus; B K Butland; D P Strachan; P C Elwood; M A Mendall
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

10.  T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Authors:  Marisa Benagiano; Annalisa Azzurri; Alessandra Ciervo; Amedeo Amedei; Carlo Tamburini; Mauro Ferrari; John L Telford; Cosima T Baldari; Sergio Romagnani; Antonio Cassone; Mario M D'Elios; Gianfranco Del Prete
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.